
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11949445
[patent_doc_number] => 20170253594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'HETEROARYL COMPOUNDS FOR KINASE INHIBITION'
[patent_app_type] => utility
[patent_app_number] => 15/600023
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84574
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600023
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600023 | Heteroaryl compounds for kinase inhibition | May 18, 2017 | Issued |
Array
(
[id] => 12346614
[patent_doc_number] => 09951041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Crystalline C
[patent_app_type] => utility
[patent_app_number] => 15/598160
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19528
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598160 | Crystalline C | May 16, 2017 | Issued |
Array
(
[id] => 14230341
[patent_doc_number] => 20190127343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => METHOD FOR PREPARING DELTA-LACTONES
[patent_app_type] => utility
[patent_app_number] => 16/095512
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095512 | Method for preparing delta-lactones | May 15, 2017 | Issued |
Array
(
[id] => 16741988
[patent_doc_number] => 10966954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
[patent_app_type] => utility
[patent_app_number] => 16/302292
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 7076
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302292
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302292 | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders | May 15, 2017 | Issued |
Array
(
[id] => 15320935
[patent_doc_number] => 20200000797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => Multi-Arm Polymeric Targeting Anti-Cancer Conjugate
[patent_app_type] => utility
[patent_app_number] => 16/300428
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300428
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300428 | Multi-arm polymeric targeting anti-cancer conjugate | May 14, 2017 | Issued |
Array
(
[id] => 12138153
[patent_doc_number] => 20180016237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'Morphan And Morphinan Analogues, And Methods Of Use'
[patent_app_type] => utility
[patent_app_number] => 15/595013
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27597
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595013
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/595013 | Morphan and morphinan analogues, and methods of use | May 14, 2017 | Issued |
Array
(
[id] => 14439349
[patent_doc_number] => 20190177547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => Quinacridone Pigment and a process for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/301210
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301210 | Quinacridone pigment and a process for preparation thereof | May 11, 2017 | Issued |
Array
(
[id] => 12254164
[patent_doc_number] => 09926297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 15/591605
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 104134
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591605
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591605 | Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists | May 9, 2017 | Issued |
Array
(
[id] => 11936429
[patent_doc_number] => 20170240580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES'
[patent_app_type] => utility
[patent_app_number] => 15/590218
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12842
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/590218 | Organic electroluminescent materials and devices | May 8, 2017 | Issued |
Array
(
[id] => 11935087
[patent_doc_number] => 20170239236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'CGRP Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 15/588051
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14067
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588051
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/588051 | CGRP receptor antagonists | May 4, 2017 | Issued |
Array
(
[id] => 15355415
[patent_doc_number] => 10526308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Adipate-type compounds and a process of preparing it
[patent_app_type] => utility
[patent_app_number] => 16/096103
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6265
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096103 | Adipate-type compounds and a process of preparing it | May 3, 2017 | Issued |
Array
(
[id] => 11866115
[patent_doc_number] => 20170233400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'METHODS FOR MAKING 3-O-PROTECTED MORPHINONES AND 3-O-PROTECTED MORPHINONE DIENOL CARBOXYLATES'
[patent_app_type] => utility
[patent_app_number] => 15/587118
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12363
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587118
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587118 | METHODS FOR MAKING 3-O-PROTECTED MORPHINONES AND 3-O-PROTECTED MORPHINONE DIENOL CARBOXYLATES | May 3, 2017 | Abandoned |
Array
(
[id] => 11866101
[patent_doc_number] => 20170233387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'ISOERGOLINE COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/586244
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16433
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586244
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586244 | Isoergoline compounds and uses thereof | May 2, 2017 | Issued |
Array
(
[id] => 11908211
[patent_doc_number] => 09777016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Isoergoline compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/586255
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16447
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586255
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586255 | Isoergoline compounds and uses thereof | May 2, 2017 | Issued |
Array
(
[id] => 14309411
[patent_doc_number] => 20190144409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => LIGNIN-BASED SOLVENTS AND METHODS FOR THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/173683
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16173683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/173683 | Lignin-based solvents and methods for their preparation | May 1, 2017 | Issued |
Array
(
[id] => 15574031
[patent_doc_number] => 10577382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Fused heterocyclic compound
[patent_app_type] => utility
[patent_app_number] => 16/094030
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57997
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094030 | Fused heterocyclic compound | Apr 26, 2017 | Issued |
Array
(
[id] => 12023621
[patent_doc_number] => 20170313720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'METHODS FOR TREATMENT OF RESISTANT CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/498788
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22102
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498788
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498788 | Methods for treatment of resistant cancer | Apr 26, 2017 | Issued |
Array
(
[id] => 13182055
[patent_doc_number] => 10106527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Isoquinolin-3-yl carboxamides and preparation and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/499013
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57552
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499013
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/499013 | Isoquinolin-3-yl carboxamides and preparation and use thereof | Apr 26, 2017 | Issued |
Array
(
[id] => 14230301
[patent_doc_number] => 20190127323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Novel Beta Lactams as Modulators of Glutamate Uptake and Methods for Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/096830
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 660
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096830
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096830 | Beta lactams as modulators of glutamate uptake and methods for use thereof | Apr 26, 2017 | Issued |
Array
(
[id] => 15227415
[patent_doc_number] => 10501417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Synthesis of indazoles
[patent_app_type] => utility
[patent_app_number] => 16/097065
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12723
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097065 | Synthesis of indazoles | Apr 24, 2017 | Issued |